Structures by: Wodtke R.
Total: 6
Methyl-2-(1-(4-(methylsulfonyl)phenyl)-3-phenyl-1H-pyrazol-5-yl)acetate
C19H18N2O4S
RSC Advances (2020) 10, 63 38601-38611
a=28.442(1)Å b=11.1139(4)Å c=11.4467(4)Å
α=90° β=90.780(2)° γ=90°
3-(2-Fluoroethyl)-1-(4-(methylsulfonyl)phenyl)-5-phenyl-1H-pyrazole
C18H17FN2O2S
RSC Advances (2020) 10, 63 38601-38611
a=11.2831(3)Å b=11.9926(3)Å c=14.2709(4)Å
α=92.663(1)° β=105.904(1)° γ=115.409(1)°
1-(3-Bromobenzoyl)-4-(4-nitrophenyl)piperazine
C17H16BrN3O3
RSC Advances (2018) 8, 71 40921
a=7.842(3)Å b=25.300(9)Å c=8.024(3)Å
α=90° β=94.67(1)° γ=90°
1-(4F-Fluorobenzoyl)-4-(4-nitrophenyl)piperazine
C17H16FN3O3
RSC Advances (2018) 8, 71 40921
a=9.7759(6)Å b=14.3497(9)Å c=10.8895(7)Å
α=90° β=101.452(2)° γ=90°
1-(4-Bromobenzoyl)-4-(4-nitrophenyl)piperazine
C17H16BrN3O3
RSC Advances (2018) 8, 71 40921
a=17.379(2)Å b=11.788(2)Å c=17.806(2)Å
α=90° β=116.727(7)° γ=90°
N,N'-Bis-(4F-fluorobenzoyl)-piperazine
C18H16F2N2O2
RSC Advances (2018) 8, 71 40921
a=6.5750(4)Å b=10.4009(7)Å c=11.2622(7)Å
α=90° β=101.313(2)° γ=90°